FHS Seminar Series - New Tuberculosis Drugs and Diagnostics: Ethical and Political Considerations
by Dr. Diego Silva, Assistant Professor, FHS
March 17, 2016 at 12:00pm to 1:15pm
Blusson Hall Room 10800, The Clamshell
The introduction and scale-up of new and emerging drugs and diagnostics to combat tuberculosis (TB) raise a host of policy and programmatic challenges both in clinical and public health settings, many of which are fundamentally ethical or political in nature. Given that it is commonly accepted that TB is a disease of poverty, despite it biological dimensions, questions arise as to the role and effects of technology in helping solve a global health problem rooted in poor social determinants of health. This presentation will address these questions by presenting preliminary results of qualitative interviews with TB policy makers, advocates, and healthcare workers, coupled with a more traditional philosophical analysis. In particular, the ideas of reciprocity, solidarity, and risk-benefit analysis, all prominent but potentially undertheorized concepts in public health ethics and global health ethics, are examined to see whether they can help elucidate or resolve challenges in present-day TB care.
Dr. Silva is an Assistant Professor in the Faculty of Health Sciences, Simon Fraser University specializing in bioethics and public health ethics. He completed his PhD at the Dalla Lana School of Public Health, University of Toronto in 2013. Prior to his appointment at SFU, Diego was a Scientist at St. Michael’s Hospital in Toronto and a Research Fellow at the Hannover Medical School in Hannover, Germany. Diego’s main research project currently focuses on ethical and political challenges related to new TB technologies, in addition to working with the World Health Organization on TB ethics.
The Seminar Series is open to the SFU Research Community. A light lunch will be available.
The FHS Research Seminar Series is an Accredited Small Group Learning by the Royal College of Physicians and Surgeons.